NCT07455942 Towards an Understanding of Barriers and Delays in the Diagnosis of Anal Cancer
| NCT ID | NCT07455942 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Intercommunal Creteil |
| Condition | Squamous Cell Carcinoma of the Anal Canal |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2026-06-23 |
| Primary Completion | 2028-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2026-06-23 with a primary completion date of 2028-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study examines care pathways in 300 patients with anal squamous cell carcinoma to identify barriers and delays in diagnosis, assess the impact of screening and access to care, and improve awareness, screening practices, and early diagnosis.
Eligibility Criteria
Inclusion Criteria: 1. Male or female ≥ 18 years 2. Histologically proven invasive or microinvasive squamous cell carcinoma of the anus 3. Having read and understood the information letter provided, either: i. After disclosure of the diagnosis, or ii. At the latest 6 months after initiation of treatment (surgical excision, radiotherapy, or chemoradiotherapy) 4. Affiliated with a social security system Exclusion Criteria: 1. Refusal to participate in the protocol 2. Other histological types: lymphoma, adenocarcinoma, neuroendocrine tumor, etc. 3. Time since treatment initiation greater than 6 months 4. Protected persons (pregnant women, breastfeeding women, individuals under guardianship or curators, minors, persons deprived of liberty, or persons unable to express informed consent).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07455942 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Squamous Cell Carcinoma of the Anal Canal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07455942 currently recruiting?
Yes, NCT07455942 is actively recruiting participants. Contact the research team at camille.jung@chicreteil.fr for enrollment information.
Where is the NCT07455942 trial being conducted?
This trial is being conducted at Angers, France, Avignon, France, Bayonne, France, Beuvry, France and 11 additional locations.
Who is sponsoring the NCT07455942 clinical trial?
NCT07455942 is sponsored by Centre Hospitalier Intercommunal Creteil. The trial plans to enroll 300 participants.